在阿尔茨海默病的抗炎药物研究中,边界和热点的演变
Shan Wu1, Nanjie Chen2, Chuanchi Wang3
1Guangdong-HongKong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China.
Behavioural brain research
|August 4, 2024
概括
这项研究分析了阿尔茨海默病 (AD) 抗炎药物研究趋势. 抗炎疗法对阿尔茨海默氏症症状缓解和认知能力改善有希望,未来的研究重点是新型药物和个性化治疗.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物医学研究生物医学研究
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因,其特征是粉样质斑块和神经纤维状结.
- 神经炎症在阿尔茨海默氏症的发病过程中起着至关重要的作用,使抗炎症策略成为有前途的治疗途径.
- 了解AD抗炎研究趋势对于推进治疗选择和改善患者生活质量至关重要.
研究的目的:
- 进行对阿尔茨海默病 (AD) 和抗炎药物研究的文献分析.
- 确定当前的研究热点和AD抗炎疗法领域的未来趋势.
- 提供一个全面的概述2000年以来的AD抗炎研究的发展.
主要方法:
- 7,638个AD抗炎研究的图书统计分析.
- 数据从科学网络核心集合 (WoSCC) 文献数据库中收集.
- 从2000年开始,研究热点和潜在趋势的分析.
主要成果:
- 研究正在迅速发展,重点是神经炎症,微质参与,以及像NSAIDs这样的抗炎药物的疗效/风险.
- 已经建立了一个全面的研究系统,从基础研究到临床研究.
- 未来的趋势包括探索AD发病的炎症,应用大数据和人工智能,开发新型抗炎药物和个性化治疗策略.
结论:
- 阿尔茨海默病的抗炎药物研究领域显示出显著的发展和广的前景.
- 预计进一步的研究和技术进步将产生更有效和更安全的AD治疗方法.
- 最终的目标是改善患者的生活质量,并延迟疾病的进展.
更多相关视频
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.2K
06:52Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
9.3K
相关概念视频
Alzheimer's Disease: Treatment
171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
